New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on: December 01,2024

New potential cancer-driving genes identified, opening new paths for precision treatments

byInstitute of Cancer ResearchStudy design and number of samples per tumor type included in the analysis. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01785-9Researchers hav

Updated on:December 01,2024

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on: January 30,2024

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on:January 30,2024

Global rise in penis cancer—what you need to know

by Colin Michie,The ConversationCredit: Pixabay/CC0 Public DomainPenis cancer is thankfully rare, butcases are rising. Some experts predict a77% increasein penis cancer by 2050

Updated on: July 05,2024

Global rise in penis cancer—what you need to know

by Colin Michie,The ConversationCredit: Pixabay/CC0 Public DomainPenis cancer is thankfully rare, butcases are rising. Some experts predict a77% increasein penis cancer by 2050

Updated on:July 05,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on: July 05,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on:July 05,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on: January 04,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on:January 04,2024

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on: March 14,2024

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on:March 14,2024

Aggressive cancer cells grow by protecting their identity, shows study

byRuhr-Universitaet-BochumGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112533For most types of cancer, the primary tumor is not the cause of death, but m

Updated on: January 22,2024

Aggressive cancer cells grow by protecting their identity, shows study

byRuhr-Universitaet-BochumGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112533For most types of cancer, the primary tumor is not the cause of death, but m

Updated on:January 22,2024

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Updated on: December 28,2023

Tackling resistance to HIF2 drugs with an RNA-based therapy

byUT Southwestern Medical CenterDownregulation of HIF2α by ARO-HIF2 in patient tumor biopsies. Credit: Dr. Payal KapurExpected to be diagnosed in 2% of men and 1% of women in the U.S., kidney ca

Updated on:December 28,2023

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an

Updated on: January 04,2024

Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an

Updated on:January 04,2024

How oxygen deprivation causes cancer cells to spread

byLeiden UniversityCredit: Pixabay/CC0 Public DomainIn breast cancer, metastasis rather than the primary tumor is the cause of death. A lack of oxygen in the tumor cells promotes this metastasis

Updated on: January 02,2024

How oxygen deprivation causes cancer cells to spread

byLeiden UniversityCredit: Pixabay/CC0 Public DomainIn breast cancer, metastasis rather than the primary tumor is the cause of death. A lack of oxygen in the tumor cells promotes this metastasis

Updated on:January 02,2024

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on: February 18,2024

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on:February 18,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on: September 10,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on:September 10,2024